
Number of publications published per year by Kahraman, Alisan. (Source : PubMed)

Distribution of publications types for Kahraman, Alisan. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Short period of preconditioning protects by decreasing the TNF-alpha and IL-6 values before laparoscopic surgery (a rat experiment).
Med. Sci. Monit.
2010;16;2
Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.
Hepatology
2010;51;1
Prognostic Assessment of Three Single-Nucleotide Polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in Extrahepatic Cholangiocarcinoma.
Cancer Invest.
2009

Apoptosis in selected liver diseases.
Turk J Gastroenterol
2009;20;3

Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.
Eur. J. Med. Res.
2009;14;9

Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.
Dig. Dis. Sci.
2009;54;9
Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse.
Hepatol. Res.
2009;39;8


Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.
Gastroenterology
2009;136;7


[A 55-year-old woman with thymoma and hypogammaglobulinemia (Good syndrome), ulcerative colitis, and cytomegalovirus infection]
Med. Klin. (Munich)
2009;104;2

Horner's syndrome from giant schwannoma of the cervical sympathetic chain: case report.
B-ENT
2009;5;2
[ See timeline ] [ See all publications ]
means that Kahraman, Alisan has 8 papers cited a least 8 times - methodology
Department of Gastroenterology, University Hospital Essen, Germany.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.